Escape Therapeutics

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2101 Clinton Rd, Hughson, California, 95...

Phone Number

(408) 960-3822

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Escape Therapeutics

Escape Therapeutics is a biotechnology company founded in 2006, focused on the discovery, development, and commercialization of innovative stem cell-based therapeutics aimed at treating severe diseases and injuries. Headquartered in Silicon Valley, California, the company boasts a team of Stanford-trained scientists specializing in stem cell immunology and genetic engineering. Their primary areas of focus include type I diabetes, acute myocardial infarction, and skin wound healing. Escape Therapeutics is on the verge of creating the world's first universal pluripotent stem cell source, positioning itself as a leader in the field of regenerative medicine.Explore more
Escape Therapeutics's Social MediaPopular SearchesEscape Therapeutics IncEscape Therapeuticsescapetherapeutics IncSIC Code 87,873NAICS Code 54,541Show more

Escape Therapeutics Org Chart

Basil Hantash, Founder, Chairman & Chief Executive Officer at Escape Therapeutics
United States flag for contact location.

Founder, Chairman & Chief Executive Officer

PhoneEmail
LZ
United States flag for contact location.

Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Escape Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Escape Therapeutics

Compare insights from companies similar to Escape Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Escape Therapeutics

<$5M
11-50
Private
-
2006
Basil Hantash, Founder, Chairman & Chief Executive Officer at Escape Therapeutics
Basil HantashFounder, Chairman & CEO
<$5M
11-50
Private
<$5M
2012
XW
Xiaofang WangVice President and Chief Technology Officer and Founder
<$5M
11-50
Private
-
-
MA
Marina AvalonPatient Care Consultant
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
BA
Ben AntebiAssociate Director
<$5M
1-10
Private
-
2006
N/A
<$5M
1-10
Private
-
2017
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Escape Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Escape Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Escape Therapeutics.

Escape Therapeutics Tech Stack

A closer look at the technologies used by Escape Therapeutics

Escape Therapeutics News & Media

  • AgeX Therapeutics Acquires Technology to Regulate Immune Tolerance

    Technology supports Company’s strategy for off-the-shelf (allogeneic) cell-based regenerative medicine products through the use of the HLA-G gene ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 16, 2018-- AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), focused on the development and commercialization of novel therapeutics targeting human aging, today announced that it has acquired certain patents and patent applications from Escape Therapeutics relating primarily to the use o
  • AgeX Therapeutics Acquires Technology to Regulate Immune Tolerance

    ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), focused on the development and commercialization of novel therapeutics targeting human aging, today announced that it has acquired certain patents and patent applications from Escape Therapeutics relating primarily to the use of the HLA-G gene to suppress rejection of transplanted cells and tissues. The Company plans to utilize the technology in conjunction with its pluripotent stem ce
  • AgeX Therapeutics Acquires Technology to Regulate Immune Tolerance

    Technology supports Company’s strategy for off-the-shelf (allogeneic) cell-based regenerative medicine products through the use of the HLA-G gene ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 16, 2018-- AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), focused on the development and commercialization of novel therapeutics targeting human aging, today announced that it has acquired certain patents and patent applications from Escape Therapeutics relating primarily to the use o
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Escape Therapeutics

What is Escape Therapeutics's official website?
Escape Therapeutics's official website is www.escapetherapeutics.com
What is Escape Therapeutics's Revenue?
Escape Therapeutics's revenue is <$5 Million
What is Escape Therapeutics's SIC code?
Escape Therapeutics's SIC: 87,873
What is Escape Therapeutics's NAICS code?
Escape Therapeutics's NAICS: 54,541
How many employees does Escape Therapeutics have?
Escape Therapeutics has 11-50 employees
What industry does Escape Therapeutics belong to?
Escape Therapeutics is in the industry of: Business Services, Research & Development
What is Escape Therapeutics competition?
Escape Therapeutics top competitors include: iOncologi, ImStem Biotechnology, Yoon Lab Group, Maryland Stem Cell Research Fund
What technology does Escape Therapeutics use?
Some of the popular technologies that Escape Therapeutics uses are: Microsoft 365, GoDaddy DNS, GoDaddy Web Hosting, jQuery
How do I contact Escape Therapeutics?
Escape Therapeutics contact info: Phone number: (408) 960-3822 Website: www.escapetherapeutics.com
What does Escape Therapeutics do?

Escape Therapeutics is a biotechnology company founded in 2006, focused on the discovery, development, and commercialization of innovative stem cell-based therapeutics aimed at treating severe diseases and injuries. Headquartered in Silicon Valley, California, the company boasts a team of Stanford-trained scientists specializing in stem cell immuno... logy and genetic engineering. Their primary areas of focus include type I diabetes, acute myocardial infarction, and skin wound healing. Escape Therapeutics is on the verge of creating the world's first universal pluripotent stem cell source, positioning itself as a leader in the field of regenerative medicine.Read More

What are Escape Therapeutics social media links?
Escape Therapeutics Linkedin page
Is Escape Therapeutics a public company?
Escape Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Escape Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.